BRIELLYN
BRIELLYN (Norethindrone and Ethinyl Estradiol Tablets, USP)
Approved
Approval ID
c0e2c5b4-70ac-4b41-aa71-00e506dbb72f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 23, 2022
Manufacturers
FDA
Glenmark Pharmaceuticals Inc., USA
DUNS: 130597813
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Norethindrone and Ethinyl Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68462-316
Application NumberANDA090538
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone and Ethinyl Estradiol
Product Specifications
Effective DateMay 23, 2022
FDA Product Classification